Clin2
NCT06616688Likely a fitNot yet recruiting

Study of pancreatic cancer tissue to stop its spread

Pancreatic Ductal Adenocarcinoma (PDAC)

Part of Cancer clinical trials.

This study looks at tissue removed during surgery for pancreatic cancer to learn how cancer spreads along nerves. The goal is to find new ways to treat it.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be 18 years old or older.
  • You are having surgery to remove a suspected pancreatic tumor (as part of your normal care).
  • You must be able to understand the study and sign a consent form.
  • The trial uses tissue removed during surgery to confirm if it is pancreatic cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07683845Recruiting
Using a tumor model to predict chemo response in pancreatic cancer

This trial tests a personalized approach by growing a miniature model of your tumor from a tissue sample. The goal is to see if this model can predict which chemotherapy will work best for you before you start treatment.

Shanghai, Shanghai Municipality
NCT07709052Not yet recruiting
Tissue markers for early diagnosis of pancreatic cancer

This study looks at tissue samples from people having surgery for a suspected pancreatic growth to find markers that might help diagnose pancreatic cancer earlier. By studying the removed tissue, researchers hope to learn more about the earliest changes that lead to cancer.

NCT04990609Recruiting· Phase 2
Study for pancreatic cancer using a biopsy-confirmed treatment approach

This Phase 2 trial is for people with pancreatic ductal adenocarcinoma (a type of pancreatic cancer) confirmed by biopsy. It tests a new treatment strategy after the cancer is diagnosed and considers people who haven’t had certain chemotherapy yet.

Houston, Texas
NCT07036978Not yet recruiting
Blood and stool study for advanced pancreatic cancer

This study looks at blood and stool samples from people with advanced pancreatic cancer to understand how their body's metabolism and gut bacteria affect their disease and treatment. It aims to find better ways to predict and improve treatment outcomes.

Taoyuan
NCT06574620Recruiting
Studying tumor DNA and proteins in pancreatic cancer

This study is looking at genetic material and proteins from pancreatic tumors to understand how the cancer responds to treatment. It aims to help doctors choose the best therapies for patients with certain types of pancreatic cancer that can be removed surgically or that have not spread to other organs.

Vancouver, British Columbia
NCT05296421Recruiting
Biopsy study during pancreatic cancer surgery to guide treatment

This study looks at specific body chemistry pathways in pancreatic cancer tissue to better understand what may help treatment work. If you are having pancreatic surgery, the researchers will take extra small tissue samples during the operation to study tumor and normal tissue.

Livingston, New Jersey

Hear when a new Pancreatic Ductal Adenocarcinoma (PDAC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.